Journal profile · RHEUMATOLOGY

Journal of Rheumatic Diseases

ISSN 2093-940X · eISSN 2233-4718 · Korean College of Rheumatology · Korea, Republic of

Journal of Rheumatic Diseases: CAS Zone 4 · Medicine (2025 upgraded edition); diamond open access (no APC); no APC; median 72 days to acceptance (89 articles, last 24 months); 53 articles in 2025; indexed in ESCI and Scopus.

Impact factor—No published value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time72 daysMedian, submission to acceptance · 89 articles, last 24 months · Crossref
APCNo APCDiamond open access (no APC)
Acceptance—No reports yet
Articles per year532025 · OpenAlex count

Scope

Aims, scope and focus

Journal of Rheumatic Diseases is published by Korean College of Rheumatology and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Spondyloarthritis Studies and Treatments, together about 36.3% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): RHEUMATOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Rheumatoid Arthritis Research and TherapiesMedicine14%
  2. Systemic Lupus Erythematosus ResearchMedicine14%
  3. Spondyloarthritis Studies and TreatmentsMedicine8.3%
  4. Vasculitis and related conditionsMedicine6.7%
  5. Autoimmune and Inflammatory Disorders ResearchMedicine6.3%
  6. Systemic Sclerosis and Related DiseasesMedicine5.3%
  7. Inflammatory Myopathies and DermatomyositisMedicine4.6%
  8. Gout, Hyperuricemia, Uric AcidMedicine3.9%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorRheumatologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorRheumatologyZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
5.5LetPub ·
SJR 2026-06
1.1LetPub ·
SNIP 2026-06
1.68LetPub ·
h-index
25OpenAlex ·
i10-index
96OpenAlex ·
2-year mean citedness
2.59OpenAlex ·
Self-citation rate
2.6%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
28LetPub ·

Articles by year OpenAlex count · 1,138 in total · the current year is incomplete

YearArticlesOpen accessCitations
202631310
2025535382
20244545252
20233939384
20223535366
20213838467

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

72 daysMedian, submission to acceptance · P25–P75 45 days – 105 days

Acceptance to online
median 21 days (89 articles)
Submission to online
median 93 days
Sample
89 articles with submission and acceptance dates (95 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 12 weeksLetPub ·
Submission to publication (journal-reported)
about 12 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Diamond open access (no APC)DOAJ

Every article is open access and authors pay no article processing charge.

SourceAPCFee waiverLicenseObserved
DOAJNo APCNoCC BY-NC
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Korean College of Rheumatology
Country or region
Korea, Republic of
Language
English
ISSN
2093-940X
Electronic ISSN
2233-4718
Official links

FAQ

Frequently asked questions about Journal of Rheumatic Diseases

What CAS zone is Journal of Rheumatic Diseases in?

In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Rheumatic Diseases is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

How long does peer review take at Journal of Rheumatic Diseases?

Based on the dates recorded on 89 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 72 days (interquartile range 45–105 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Journal of Rheumatic Diseases?

According to LetPub and DOAJ records, Journal of Rheumatic Diseases is indexed in ESCI, Scopus and DOAJ.

Is Journal of Rheumatic Diseases open access, and what is the APC?

Journal of Rheumatic Diseases is a diamond open-access journal (no APC). It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .